Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).
Polis MA, deSmet MD, Baird BF, Mellow S, Falloon J, Davey RT, Kovacs JA, Palestine AG, Nussenblatt RB, Masur H, et al. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). Am J Med. 1993 Feb; 94(2):175-80.